Mefkure Eraslan Şahin(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0001-6484-9132
İlknur Çöl Madendağ(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0001-6700-2236
Esra Akdemir(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0002-3776-0674
Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
📊
Key Findings & Data:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
💡
Conclusion & Impact:Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Maternal kalp hastalığı · mWHO sınıflandırması · Olumsuz perinatal sonuçlar
Abstract
Objective: The aim of the present study was to evaluate the effect of severe maternal cardiac disease during pregnancy on mode of delivery and adverse perinatal outcomes.
Özet
Amaç: Bu çalışmanın amacı, gebelik sırasındaki ciddi maternal kalp hastalığının doğum şekli ve olumsuz perinatal sonuçlar üzerindeki etkisini değerlendirmektir.
Kırlangıç, M. M., Madendağ, Y., Şahin, E., Şahin, M. E., Madendağ, İ. Ç., Açmaz, G., Akdemir, E., Yalman, M. V. (2021). EVALUATION OF MATERNAL HEART DISEASE EFFECTS ON MODE OF DELIVERY AND ADVERSE PERINATAL OUTCOMES: A 10 YEARS’ EXPERIENCE OF A REFERENCE CENTER. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 Sayı: 3, 514–521. https://doi.org/10.24938/kutfd.954241
Fett JD. Peripartum cardiomyopathy: challenges in diagnosis and management. Expert Rev Cardiovasc Ther. 2016;14(9):1035-41.
Hameed AB, Lawton ES, McCain CL, Morton CH, Mitchell C, Main EK et al. Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015;213(3):379.e1-e10.
Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118(3):583-91.
Kuklina EV, Callaghan WM. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG. 2011;118(3):345-52.
Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118:1-203.
Köşüş A, Köşüş N, Açıkgöz N, Çapar M. Kalp hastalığı olan ve olmayan gebelerde maternal ve fetal sonuçlar açisindan bir fark var mı? Genel Tıp Dergisi. 2008;18(2):55-60.
Ayşegül Ö, Hamzaoğlu K, Durmaz E, Madazlı R. Pregnancy outcomes of 115 cases with maternal heart disease. İstanbul Tıp Fakültesi Dergisi. 2020;83(1);17-22.
Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657-65.
Pavankumar P, Venugopal P, Kaul U, Iyer K, Das B, Sampathkumar A et al. Pregnancy in patients with prosthetic cardiac valve: a 10-year experience. Scand J Thorac Cardiovasc Surg. 1988;22(1):19-22.
Jeejeebhoy FM. Prosthetic heart valves and management during pregnancy. Can Fam Physician. 2009;55(2):155.
Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA. Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol. 2015;126(2):346.
Erolu E, Sarısoy Ö. Fetal echocardiography characteristics in a tertiary center. Erciyes Med J. 2020;42(2):143-6.
Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303-11.
Madazli R, Şal V, Çift T, Guralp O, Goymen A. Pregnancy outcomes in women with heart disease. Arch Gynecol Obstet. 2010;281(1):29.
Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530-6.
Endorsed by the European Society of Gynecology tAfEPC, Medicine tGSfG, Members ATF, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147-97.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cifkova R, De Bonis M et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(34):3165-241.
Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol. 2016;68(4):396-410.